Sany Hoxha

Sany Hoxha currently serves as the Director of Oncology Translational Science and Clinical Biomarkers at Merck since April 2025. Prior to this role, Sany was the Oncology Translational and Biomarker Manager at Calico Life Sciences from September 2021 to April 2025, where responsibilities included leading biomarker strategies for oncology programs in collaboration with AbbVie. Earlier experience includes roles as Oncology Translational and Biomarker Lead at Calico, Bioanalytical Lead at AstraZeneca focusing on pharmacodynamic biomarkers, and Biomarker Scientist at Pharmacyclics. Sany began a career in research as a Postdoctoral Scientist at Scripps Research. Educational qualifications include a Doctor of Philosophy (Ph.D.) in Oncology and Cancer Biology from Scripps Research and a Bachelor of Arts (B.A.) in Biology from Florida Atlantic University.